[MNPR] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[MNPR] Monopar Therapeutics Inc.
Announcement Date
12-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 18.76%
YoY- -15.00%
Quarter Report
MNPR's Result
MNPR's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -2,400 -2,458 -1,639 -736 -640 -14,877 -193 52.18%
Tax -15 -2,459 -1,648 -759 -668 -396 4 -
NP -2,384 -2,458 -1,639 -736 -640 -14,877 -193 52.01%
Tax Rate - - - - - - - -
Total Cost 2,384 2,458 1,639 736 640 14,877 193 52.01%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.19 -0.20 -0.15 -0.07 -0.06 -1.43 -0.02 45.50%
EPS Diluted -0.19 -0.20 -0.15 -0.07 -0.06 -1.43 -0.02 45.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.